AAAAAA

   
Results: 1-10 |
Results: 10
EFFECT OF A HUMANIZED NON-DEPLETING ANTI-CD4 MONOCLONAL-ANTIBODY (MAB) ON SYNOVIAL-FLUID (SF) IN RHEUMATOID-ARTHRITIS (RA)
Authors: CHOY EHS CONNOLLY DJA RAPSON N KINGSLEY GH JOHNSTON JM PANAYI GS
Citation: Ehs. Choy et al., EFFECT OF A HUMANIZED NON-DEPLETING ANTI-CD4 MONOCLONAL-ANTIBODY (MAB) ON SYNOVIAL-FLUID (SF) IN RHEUMATOID-ARTHRITIS (RA), Arthritis and rheumatism, 40(9), 1997, pp. 130-130
EMERGENCE OF CD52(-), GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHOR-DEFICIENT LYMPHOCYTES IN RHEUMATOID-ARTHRITIS PATIENTS FOLLOWING CAMPATH-1H TREATMENT
Authors: BRETT SJ BAXTER G COOPER H ROWAN W REGAN T TITE J RAPSON N
Citation: Sj. Brett et al., EMERGENCE OF CD52(-), GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHOR-DEFICIENT LYMPHOCYTES IN RHEUMATOID-ARTHRITIS PATIENTS FOLLOWING CAMPATH-1H TREATMENT, International immunology, 8(3), 1996, pp. 325-334
CAMPATH-1H IN RHEUMATOID-ARTHRITIS - AN INTRAVENOUS DOSE-RANGING STUDY
Authors: ISAACS JD MANNA VK RAPSON N BULPITT KJ HAZLEMAN BL MATTESON EL STCLAIR EW SCHNITZER TJ JOHNSTON JM
Citation: Jd. Isaacs et al., CAMPATH-1H IN RHEUMATOID-ARTHRITIS - AN INTRAVENOUS DOSE-RANGING STUDY, British journal of rheumatology, 35(3), 1996, pp. 231-240
T-CELL HYPOTHESIS IN RHEUMATOID-ARTHRITIS (RA) TESTED BY HUMANIZED NON-DEPLETING ANTI-CD4 MONOCLONAL-ANTIBODY (MAB) TREATMENT .2. CLINICAL ACTIVITY IS RELATED TO PHARMACODYNAMIC EFFECTS
Authors: CHOY EHS CONNOLLY DJA REGAN T MANNA VK RAPSON N KINGSLEY GH PANAYI GS JOHNSTON JM
Citation: Ehs. Choy et al., T-CELL HYPOTHESIS IN RHEUMATOID-ARTHRITIS (RA) TESTED BY HUMANIZED NON-DEPLETING ANTI-CD4 MONOCLONAL-ANTIBODY (MAB) TREATMENT .2. CLINICAL ACTIVITY IS RELATED TO PHARMACODYNAMIC EFFECTS, Immunology, 89, 1996, pp. 378-378
T-CELL HYPOTHESIS IN RHEUMATOID-ARTHRITIS (RA) TESTED BY HUMANIZED NON-DEPLETING ANTI-CD4 MONOCLONAL-ANTIBODY (MAB) TREATMENT .1. SUPPRESSION OF DISEASE-ACTIVITY AND ACUTE-PHASE RESPONSE
Authors: PANAYI GS CHOY EHS CONNOLLY DJA MANNA VK REGAN T RAPSON N KINGSLEY GH JOHNSTON JM
Citation: Gs. Panayi et al., T-CELL HYPOTHESIS IN RHEUMATOID-ARTHRITIS (RA) TESTED BY HUMANIZED NON-DEPLETING ANTI-CD4 MONOCLONAL-ANTIBODY (MAB) TREATMENT .1. SUPPRESSION OF DISEASE-ACTIVITY AND ACUTE-PHASE RESPONSE, Immunology, 89, 1996, pp. 379-379
REPOPULATION OF BLOOD LYMPHOCYTE SUBPOPULATIONS IN RHEUMATOID-ARTHRITIS PATIENTS TREATED WITH THE DEPLETING HUMANIZED MONOCLONAL-ANTIBODY, CAMPATH-1H
Authors: BRETT S BAXTER G COOPER H JOHNSTON JM TITE J RAPSON N
Citation: S. Brett et al., REPOPULATION OF BLOOD LYMPHOCYTE SUBPOPULATIONS IN RHEUMATOID-ARTHRITIS PATIENTS TREATED WITH THE DEPLETING HUMANIZED MONOCLONAL-ANTIBODY, CAMPATH-1H, Immunology, 88(1), 1996, pp. 13-19
CELL HYPOTHESIS IN RHEUMATOID-ARTHRITIS (RA) TESTED BY HUMANIZED NON-DEPLETING ANTI-CD4 MONOCLONAL-ANTIBODY (MAB) TREATMENT .1. SUPPRESSIONOF DISEASE-ACTIVITY AND ACUTE-PHASE RESPONSE
Authors: PANAYI GS CHOY EHS CONNOLLY DJA REGAN T MANNA VK RAPSON N KINGSLEY GH JOHNSTON JM
Citation: Gs. Panayi et al., CELL HYPOTHESIS IN RHEUMATOID-ARTHRITIS (RA) TESTED BY HUMANIZED NON-DEPLETING ANTI-CD4 MONOCLONAL-ANTIBODY (MAB) TREATMENT .1. SUPPRESSIONOF DISEASE-ACTIVITY AND ACUTE-PHASE RESPONSE, Arthritis and rheumatism, 39(9), 1996, pp. 1300-1300
CELL HYPOTHESIS IN RHEUMATOID-ARTHRITIS (RA) TESTED BY HUMANIZED NON-DEPLETING ANTI-CD4 MONOCLONAL-ANTIBODY (MAB) TREATMENT .2. CLINICAL ACTIVITY IS RELATED TO PHARMACODYNAMIC EFFECTS
Authors: CHOY EHS CONNOLLY DJA REGAN T MANNA VK RAPSON N KINGSLEY GH PANAYI GS JOHNSTON JM
Citation: Ehs. Choy et al., CELL HYPOTHESIS IN RHEUMATOID-ARTHRITIS (RA) TESTED BY HUMANIZED NON-DEPLETING ANTI-CD4 MONOCLONAL-ANTIBODY (MAB) TREATMENT .2. CLINICAL ACTIVITY IS RELATED TO PHARMACODYNAMIC EFFECTS, Arthritis and rheumatism, 39(9), 1996, pp. 1301-1301
T-CELL HYPOTHESIS IN RHEUMATOID-ARTHRITIS (RA) TESTED BY HUMANIZED NON-DEPLETING ANTI-CD4 MONOCLONAL-ANTIBODY (MAB) TREATMENT .3. IMMUNOLOGICAL EFFECTS
Authors: CONNOLLY DJA CHOY EHS RAPSON N REGAN T KINGSLEY GH JOHNSTON JM PANAYI GS
Citation: Dja. Connolly et al., T-CELL HYPOTHESIS IN RHEUMATOID-ARTHRITIS (RA) TESTED BY HUMANIZED NON-DEPLETING ANTI-CD4 MONOCLONAL-ANTIBODY (MAB) TREATMENT .3. IMMUNOLOGICAL EFFECTS, Arthritis and rheumatism, 39(9), 1996, pp. 1302-1302
CHANGE IN LYMPHOCYTE SUBPOPULATIONS IN RHEUMATOID-ARTHRITIS PATIENTS TREATED WITH A HUMANIZED MONOCLONAL-ANTIBODY
Authors: THURMOND L COOPER H RAPSON N REESE M KARDISH M FREEDMAN J HEITMAN C REGAN T MANNA V JOHNSTON J
Citation: L. Thurmond et al., CHANGE IN LYMPHOCYTE SUBPOPULATIONS IN RHEUMATOID-ARTHRITIS PATIENTS TREATED WITH A HUMANIZED MONOCLONAL-ANTIBODY, The Journal of immunology, 150(8), 1993, pp. 164-164
Risultati: 1-10 |